The global long-read sequencing market is expected to witness significant growth over the next decade driven by technological advancements and increasing applications in clinical diagnostics and research. Long-read sequencing technologies offer several advantages over traditional short-read sequencing and are gaining adoption in applications that were previously challenging using short reads.
Get a Sample Copy of the Market Research Report (Use Corporate Mail Id for Quick Response) –
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77289
Long-read sequencing refers to third-generation DNA sequencing technologies that can generate read lengths of over 10,000 bases, significantly longer than the 600 bases produced by short-read second-generation technologies like Illumina. The ability to sequence much longer reads allows long-read sequencing to resolve complex genomic regions and detect structural variants that are difficult to analyze with short fragments. Some of the key long-read sequencing technologies currently available include Pacific Biosciences’ Single Molecule, Real-Time (SMRT) sequencing and Oxford Nanopore Technologies’ nanopore sequencing.
The ability to generate long reads is fueling the use of long-read sequencing in de novo genome assembly. While short reads require complex bioinformatics techniques and reference genomes to map reads and assemble genomes, long reads can be directly used to assemble genomes without a reference. This is enabling the assembly of complex genomes that were challenging to analyze previously. Long-read sequencing is also improving transcriptome analysis by allowing full-length isoform sequencing and detection of splice variants.
In clinical diagnostics, long-read sequencing is enhancing detection of disease-causing structural variants. It is improving resolution of human leukocyte antigen (HLA) typing for transplantation matching. Using long-range PCR and long reads provides better characterization of disease genes and differentiation from pseudogenes. These advantages are driving increased adoption of long-read sequencing for clinical genetic testing and research.
North America currently dominates the long-read sequencing market due to extensive R&D activities and supportive regulatory environment. Presence of leading market players and availability of reimbursements are fueling market growth. However, the high cost of long-read sequencing platforms and consumables as compared to short-read technologies remains a key challenge. The Asia Pacific region is anticipated to emerge as a major market during the forecast period driven by the expansion of genomics research and biotech industry in China, Japan and India.
The global long-read sequencing market is highly competitive with Pacific Biosciences and Oxford Nanopore Technologies having the largest shares. Other notable players include Quantapore, Stratos Genomics and MicrobesNG. Leading market participants are focusing on reducing sequencing costs through technological advancements to drive broader adoption. Partnerships with clinical laboratories and diagnostic companies are also a key focus to increase clinical applications of long-read sequencing.
Over the coming years, as long-read sequencing costs continue to decline, applications in clinical diagnostics will increase significantly. Widespread clinical use will require extensive validation studies and regulatory approvals. Long-read sequencing is also finding new applications in metagenomics, DNA nanotechnology and epigenetics that will support market growth. While short-read technologies still have advantages in throughput and cost-effectiveness for large cohorts, long-read sequencing is gaining ground in applications requiring structural or isoform resolution. The market is expected to grow at a CAGR of over 15% through 2030. Continued technological innovations to improve throughput, reduce errors and bring down costs will be crucial for long-read sequencing to achieve broader clinical and research adoption.
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact Us
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453